Drug General Information (ID: DDIAYO4NRT)
  Drug Name Disopyramide Drug Info Lidocaine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiarrhythmic Agents Anesthetics
  Structure

 Mechanism of Disopyramide-Lidocaine Interaction (Severity Level: Moderate)
     Increased risk of cardiac depression Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Disopyramide Lidocaine
      Mechanism Cardiac depressant effects Cardiac depressant effects
      Key Mechanism Factor 1
Factor Name Cardiac depression
Factor Description Cardiac depression may manifest as negative heart rate, negative conduction, and negative contractility. Symptoms include: excessive or more than normal sleep, irritability, loss of interest in activities, and fatigue.
      Mechanism Description
  • Increased risk of cardiac depression by the combination of Disopyramide and Lidocaine 

Recommended Action
      Management Patients should be closely monitored for hemodynamic and electrocardiographic evidence of efficacy and toxicity during concomitant administration.

References
1 Ellrodt G, Singh BN "Adverse effects of disopyramide (norpace): toxic interactions with other antiarrhythmic agents." Heart Lung 9 (1980): 469-74. [PMID: 6901519]
2 Product Information. Norpace (disopyramide). Searle, Skokie, IL.